<DOC>
	<DOCNO>NCT00626184</DOCNO>
	<brief_summary>To assess safety tolerability ALV003 healthy volunteer patient Celiac Disease</brief_summary>
	<brief_title>A Phase 1 , Study Safety Tolerability ALV003 Healthy Adult Volunteers Subjects With Well-Controlled Celiac Disease</brief_title>
	<detailed_description>A Phase 1 , Two Stage , Single Dose , Single-Blind , Placebo Controlled , Dose Escalation , Crossover Study Safety Tolerability ALV003 Healthy Adult Volunteers Subjects With Well-Controlled Celiac Disease</detailed_description>
	<mesh_term>Celiac Disease</mesh_term>
	<criteria>INCLUSION Health Status 1 . Healthy volunteer must good health 2 . Celiac Disease must well control good health Either male nonlactating , nonpregnant female postmenopausal , sterile use least two acceptable highly effective birth control method . Body Mass Index ( BMI ) &lt; 30 kg/m2 , EXCLUSION A positive urine test alcohol illegal drug screen . The subject receive experimental drug within 30 day present study . History substance abuse , within last 5 year Clinically significant abnormal lab value , determine PI Alcohol consumption &gt; 2 standard drink equivalent per day12 . Positive pregnancy test within 7 day prior study drug administration . history medically significant condition consider PI adversely affect participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Celiac Disease</keyword>
</DOC>